Cannabotech Ltd
CannaboTech Ltd engages in developing cannabinoid-based medication and healthcare products. It provides drugs for various indications; personalized cannabinoid-based products; and CBD-based skincare and food-supplement products. The company was incorporated in 2019 and is based in Rishon LeZion, Israel.
Market Cap & Net Worth: Cannabotech Ltd (CNTC)
Cannabotech Ltd (TA:CNTC) has a market capitalization of $89.99K (ILA33.57 Million) as of March 19, 2026. Listed on the TA stock exchange, this Israel-based company holds position #48274 globally and #470 in its home market, demonstrating a -34.55% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cannabotech Ltd's stock price ILA82.20 by its total outstanding shares 408363 (408.36K).
Cannabotech Ltd Market Cap History: 2021 to 2025
Cannabotech Ltd's market capitalization history from 2021 to 2025. Data shows change from $3.84 Million to $89.99K (-63.22% CAGR).
Cannabotech Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cannabotech Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CNTC by Market Capitalization
Companies near Cannabotech Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Cannabotech Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Cannabotech Ltd Historical Marketcap From 2021 to 2025
Between 2021 and today, Cannabotech Ltd's market cap moved from $3.84 Million to $ 89.99K, with a yearly change of -63.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ILA89.99K | -36.43% |
| 2024 | ILA141.56K | -73.49% |
| 2023 | ILA533.94K | -64.09% |
| 2022 | ILA1.49 Million | -61.30% |
| 2021 | ILA3.84 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Cannabotech Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $89.99K USD |
| MoneyControl | $89.99K USD |
| MarketWatch | $89.99K USD |
| marketcap.company | $89.99K USD |
| Reuters | $89.99K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.